$1.58 Billion is the total value of Bellevue Group AG's 138 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 13.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ANTM | Buy | ANTHEM INC | $61,439,000 | +20.9% | 224,188 | +5.0% | 3.90% | -10.1% |
| ALGN | Buy | ALIGN TECHNOLOGY INC | $57,239,000 | +27.7% | 146,310 | +11.6% | 3.63% | -5.0% |
| ABT | Buy | ABBOTT LABS | $56,246,000 | +62.1% | 766,710 | +34.8% | 3.57% | +20.6% |
| CELG | Buy | CELGENE CORP | $54,231,000 | +28.2% | 606,000 | +13.7% | 3.44% | -4.6% |
| ILMN | Buy | ILLUMINA INC | $54,217,000 | +37.7% | 147,707 | +4.8% | 3.44% | +2.4% |
| TDOC | Buy | TELADOC HEALTH INC | $50,646,000 | +53.0% | 586,520 | +2.9% | 3.21% | +13.9% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $50,436,000 | +20.1% | 87,868 | +0.1% | 3.20% | -10.6% |
| MDT | Buy | MEDTRONIC PLC | $48,835,000 | +41.9% | 496,446 | +23.5% | 3.10% | +5.6% |
| EW | Buy | EDWARDS LIFESCIENCES CORP | $44,105,000 | +47.3% | 253,333 | +23.2% | 2.80% | +9.6% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $37,689,000 | +40.5% | 978,929 | +19.3% | 2.39% | +4.5% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $35,939,000 | +26.5% | 213,758 | +29.6% | 2.28% | -5.9% |
| CI | Buy | CIGNA CORPORATION | $35,291,000 | +64.5% | 169,463 | +34.2% | 2.24% | +22.4% |
| HUM | Buy | HUMANA INC | $33,348,000 | +29.0% | 98,510 | +13.4% | 2.12% | -4.0% |
| UNH | Buy | UNITEDHEALTH GROUP INC | $32,949,000 | +38.8% | 123,848 | +28.0% | 2.09% | +3.3% |
| CNC | Buy | CENTENE CORP DEL | $31,565,000 | +56.9% | 218,021 | +33.6% | 2.00% | +16.7% |
| BDX | Buy | BECTON DICKINSON & CO | $27,513,000 | +41.4% | 105,413 | +29.8% | 1.74% | +5.2% |
| DHR | Buy | DANAHER CORP DEL | $27,493,000 | +27.5% | 253,016 | +15.8% | 1.74% | -5.1% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $25,450,000 | +25.2% | 183,080 | +11.8% | 1.61% | -6.9% |
| SYK | Buy | STRYKER CORP | $25,120,000 | +25.2% | 141,380 | +19.0% | 1.59% | -6.8% |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $21,215,000 | +47.0% | 341,729 | +31.0% | 1.35% | +9.3% |
| MYL | Buy | MYLAN N V | $20,692,000 | +14.0% | 565,350 | +12.5% | 1.31% | -15.2% |
| BAX | Buy | BAXTER INTL INC | $20,301,000 | +30.9% | 263,348 | +25.4% | 1.29% | -2.6% |
| SUPN | Buy | SUPERNUS PHARMACEUTICALS INC | $19,460,000 | -0.4% | 386,500 | +18.3% | 1.23% | -25.9% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $19,245,000 | +88.8% | 219,891 | +112.5% | 1.22% | +40.5% |
| PRAH | Buy | PRA HEALTH SCIENCES INC | $18,336,000 | +51.8% | 166,400 | +28.6% | 1.16% | +12.9% |
| WMGI | Buy | WRIGHT MED GROUP NV | $18,071,000 | +22.1% | 622,692 | +9.2% | 1.15% | -9.2% |
| HRC | Buy | HILL ROM HLDGS INC | $17,529,000 | +11.7% | 185,689 | +3.3% | 1.11% | -16.9% |
| ESPR | Buy | ESPERION THERAPEUTICS INC NEW | $17,386,000 | +41.5% | 391,852 | +25.0% | 1.10% | +5.3% |
| LH | Buy | LABORATORY CORP AMER HLDGS | $16,333,000 | +20.9% | 94,040 | +25.0% | 1.04% | -10.1% |
| MGNX | Buy | MACROGENICS INC | $15,529,000 | +26.0% | 724,302 | +21.3% | 0.98% | -6.3% |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $15,072,000 | +25.7% | 905,254 | +19.3% | 0.96% | -6.5% |
| ABMD | Buy | ABIOMED INC | $14,902,000 | +34.5% | 33,135 | +22.4% | 0.94% | +0.1% |
| AKCA | Buy | AKCEA THERAPEUTICS INC | $14,656,000 | +63.0% | 418,496 | +10.3% | 0.93% | +21.3% |
| LIVN | Buy | LIVANOVA PLC | $14,435,000 | +31.6% | 116,443 | +5.9% | 0.92% | -2.0% |
| PACB | New | PACIFIC BIOSCIENCES OF CALIF INC | $13,931,000 | – | 2,575,000 | +100.0% | 0.88% | – |
| FIT | Buy | FITBIT INCcl a | $13,449,000 | +0.1% | 2,513,900 | +22.2% | 0.85% | -25.6% |
| HCM | Buy | HUTCHISON CHINA MEDITECH LTDsponsored adr | $12,877,000 | +28.5% | 400,029 | +20.3% | 0.82% | -4.3% |
| ZBH | Buy | ZIMMER BIOMET HLDGS INC | $12,109,000 | +52.2% | 92,104 | +29.0% | 0.77% | +13.3% |
| INSM | Buy | INSMED INC | $11,451,000 | +14.2% | 566,301 | +33.5% | 0.73% | -15.1% |
| RMD | Buy | RESMED INC | $10,749,000 | +26.3% | 93,192 | +13.4% | 0.68% | -6.1% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $10,295,000 | +72.9% | 25,480 | +47.6% | 0.65% | +28.5% |
| GNMK | Buy | GENMARK DIAGNOSTICS INC | $9,845,000 | +30.1% | 1,339,502 | +12.9% | 0.62% | -3.1% |
| CDNA | New | CAREDX INC | $9,724,000 | – | 337,049 | +100.0% | 0.62% | – |
| IART | Buy | INTEGRA LIFESCIENCES HLDGS C | $9,329,000 | +149.0% | 141,620 | +143.5% | 0.59% | +85.6% |
| WCG | Buy | WELLCARE HEALTH PLANS INC | $9,060,000 | +66.9% | 28,269 | +28.2% | 0.58% | +24.2% |
| GMED | Buy | GLOBUS MED INCcl a | $8,585,000 | +129.8% | 151,251 | +104.3% | 0.54% | +70.8% |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $8,414,000 | +39.4% | 34,471 | +18.3% | 0.53% | +3.9% |
| OMCL | Buy | OMNICELL INC | $7,524,000 | +124.3% | 104,650 | +63.7% | 0.48% | +66.8% |
| HMSY | Buy | HMS HLDGS CORP | $7,449,000 | +135.9% | 227,020 | +55.4% | 0.47% | +75.8% |
| TRHC | Buy | TABULA RASA HEALTHCARE INC | $7,054,000 | +64.2% | 86,884 | +29.1% | 0.45% | +22.1% |
| XENT | Buy | INTERSECT ENT INC | $6,734,000 | +104.2% | 234,227 | +166.1% | 0.43% | +52.0% |
| QTRX | Buy | QUANTERIX CORP | $6,709,000 | +182.4% | 313,230 | +89.3% | 0.43% | +109.9% |
| IRTC | Buy | IRHYTHM TECHNOLOGIES INC | $6,594,000 | +77.0% | 69,661 | +51.7% | 0.42% | +31.4% |
| COO | Buy | COOPER COS INC | $6,322,000 | +39.1% | 22,811 | +18.2% | 0.40% | +3.6% |
| IDXX | Buy | IDEXX LABS INC | $6,068,000 | +297.6% | 24,307 | +247.2% | 0.38% | +196.2% |
| INGN | Buy | INOGEN INC | $5,678,000 | +407.0% | 23,261 | +287.0% | 0.36% | +278.9% |
| QTNT | Buy | QUOTIENT LTD | $5,450,000 | +112.2% | 721,858 | +125.7% | 0.35% | +58.0% |
| HCA | Buy | HCA HEALTHCARE INC | $5,132,000 | +163.3% | 36,888 | +94.1% | 0.33% | +96.4% |
| QGEN | Buy | QIAGEN NV | $5,083,000 | +83.0% | 134,189 | +74.6% | 0.32% | +35.9% |
| TFX | Buy | TELEFLEX INC | $4,734,000 | +26.1% | 17,792 | +27.1% | 0.30% | -6.2% |
| NVRO | Buy | NEVRO CORP | $4,584,000 | +122.5% | 80,415 | +211.7% | 0.29% | +65.3% |
| HZNP | Buy | HORIZON PHARMA PLC | $4,340,000 | +36.8% | 221,678 | +15.7% | 0.28% | +1.5% |
| XRAY | Buy | DENTSPLY SIRONA INC | $4,185,000 | +27.3% | 110,878 | +47.7% | 0.26% | -5.4% |
| CERN | Buy | CERNER CORP | $3,810,000 | +10.1% | 59,146 | +2.2% | 0.24% | -18.0% |
| INSP | Buy | INSPIRE MED SYS INC | $3,816,000 | +123.2% | 90,696 | +89.1% | 0.24% | +65.8% |
| ENDP | Buy | ENDO INTL PLC | $3,659,000 | +291.8% | 217,392 | +119.4% | 0.23% | +190.0% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLC | $3,600,000 | +152.5% | 221,837 | +100.5% | 0.23% | +86.9% |
| STIM | Buy | NEURONETICS INC | $3,588,000 | +171.8% | 111,907 | +123.8% | 0.23% | +101.8% |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $3,563,000 | +28.6% | 215,935 | +9.1% | 0.23% | -4.2% |
| VEEV | Buy | VEEVA SYS INC | $3,559,000 | +349.9% | 32,691 | +217.5% | 0.23% | +237.3% |
| IBB | New | ISHARES TRnasdaq biotech | $3,414,000 | – | 28,000 | +100.0% | 0.22% | – |
| NKTR | Buy | NEKTAR THERAPEUTICS | $3,384,000 | +100.8% | 55,520 | +60.9% | 0.22% | +49.3% |
| AMED | New | AMEDISYS INC | $3,149,000 | – | 25,204 | +100.0% | 0.20% | – |
| MTLS | Buy | MATERIALISE NVsponsored ads | $2,908,000 | +470.2% | 210,731 | +435.8% | 0.18% | +327.9% |
| PEN | Buy | PENUMBRA INC | $2,866,000 | +47.9% | 19,142 | +36.5% | 0.18% | +10.3% |
| MDSO | Buy | MEDIDATA SOLUTIONS INC | $2,706,000 | +621.6% | 36,907 | +693.9% | 0.17% | +437.5% |
| AGN | Buy | ALLERGAN PLC | $2,476,000 | +48.5% | 13,000 | +30.0% | 0.16% | +10.6% |
| MASI | Buy | MASIMO CORP | $2,426,000 | +67.9% | 19,476 | +31.6% | 0.15% | +25.2% |
| CSLT | Buy | CASTLIGHT HEALTH INCcl b | $2,400,000 | +96.6% | 888,842 | +209.3% | 0.15% | +46.2% |
| SRPT | New | SAREPTA THERAPEUTICS INC | $2,116,000 | – | 13,100 | +100.0% | 0.13% | – |
| AMRX | Buy | AMNEAL PHARMACEUTICALS INC | $2,108,000 | +71.2% | 95,000 | +26.7% | 0.13% | +27.6% |
| BGNE | Buy | BEIGENE LTDsponsored adr | $2,001,000 | +13.2% | 11,620 | +1.0% | 0.13% | -15.9% |
| TSRO | Buy | TESARO INC | $1,504,000 | +33.9% | 38,550 | +52.7% | 0.10% | -1.0% |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $1,466,000 | – | 79,400 | +100.0% | 0.09% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $1,183,000 | – | 57,000 | +100.0% | 0.08% | – |
| PTCT | New | PTC THERAPEUTICS INC | $1,058,000 | – | 22,500 | +100.0% | 0.07% | – |
| XLRN | New | ACCELERON PHARMA INC | $927,000 | – | 16,200 | +100.0% | 0.06% | – |
| VYGR | Buy | VOYAGER THERAPEUTICS INC | $822,000 | +148.3% | 43,422 | +156.6% | 0.05% | +85.7% |
| PINC | New | PREMIER INCcl a | $691,000 | – | 15,100 | +100.0% | 0.04% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $281,000 | – | 25,000 | +100.0% | 0.02% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Bellevue Asset Management AG #1
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IONIS PHARMACEUTICALS INC | 31 | Q3 2023 | 9.3% |
| Vertex Pharmaceuticals Incorporated | 31 | Q3 2023 | 5.9% |
| NEUROCRINE BIOSCIENCES INC | 31 | Q3 2023 | 5.7% |
| Incyte Corporation | 31 | Q3 2023 | 5.4% |
| INTUITIVE SURGICAL INC | 31 | Q3 2023 | 4.7% |
| ABBOTT LABS | 31 | Q3 2023 | 4.6% |
| ELEVANCE HEALTH INC | 31 | Q3 2023 | 4.3% |
| UnitedHealth Group Incorporated | 31 | Q3 2023 | 3.6% |
| ALNYLAM PHARMACEUTICALS INC | 31 | Q3 2023 | 3.7% |
| Boston Scientific Corporation | 31 | Q3 2023 | 2.5% |
View Bellevue Group AG's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G | 2023-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Bellevue Group AG's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.